Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 2016 updated EULAR evidence-based recommendations for the management of gout1 passage
• 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis1 passage
• 2018 update of the EULAR recommendations for the management of hand osteoarthritis1 passage
• 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout1 passage
• 2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older1 passage
• 2023 EULAR recommendations on imaging in diagnosis and management of crystal-induced arthropathies in clinical practice1 passage
• Arthroscopic partial meniscectomy versus placebo surgery for a degenerative meniscus tear: a 2-year follow-up of the randomised controlled trial1 passage
• Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study1 passage
• EULAR recommendations for intra-articular therapies1 passage
• EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update1 passage
• EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis1 passage
• EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome1 passage
• Genome-wide association meta-analysis of knee and hip osteoarthritis uncovers genetic differences between patients treated with joint replacement and patients without joint replacement1 passage
• Genome-wide association study revealed novel loci which aggravate asymptomatic hyperuricaemia into gout1 passage
• Identifying the association between serum urate levels and gout flares in patients taking urate-lowering therapy: a post hoc cohort analysis of the CARES trial with consideration of dropout1 passage
• Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial1 passage
• Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)1 passage
• Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study1 passage
• Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta-analysis from the OA trial bank1 passage
• Systematic literature review to inform the EULAR recommendations for the use of imaging in crystal-induced arthropathies in clinical practice1 passage
• Twenty-eight loci that influence serum urate levels: analysis of association with gout1 passage
• Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial1 passage
• Update of EULAR recommendations for the treatment of systemic sclerosis1 passage
• Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies1 passage